首页 正文

Diabetes care. 2024 Dec 1;47(12):e102-e103. doi: 10.2337/dc24-1163 Q116.62025

Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Glibenclamide in a Young Adult With KCNJ11 Permanent Neonatal Diabetes

用于治疗KCNJ11永久新生儿糖尿病的胰高血糖素样肽-1受体激动剂与格列本脲联合应用的病例报告 翻译改进

Mairéad T Crowley  1, Sarah Roarty  2, Helen O'Shea  1, Andrew T Hattersley  3, Maria M Byrne  1

作者单位 +展开

作者单位

  • 1 Department of Endocrinology & Diabetes, Mater Misericordiae University Hospital, Dublin, Ireland.
  • 2 Department of Emergency Medicine, Temple Street Hospital, Dublin, Ireland.
  • 3 Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
  • DOI: 10.2337/dc24-1163 PMID: 39403023

    摘要 中英对照阅读

    Copyright © Diabetes care. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Diabetes care

    缩写:DIABETES CARE

    ISSN:0149-5992

    e-ISSN:1935-5548

    IF/分区:16.6/Q1

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Glibenclamide in a Young Adult With KCNJ11 Permanent Neonatal Diabetes